Drone Maker Kratos Jumps on Strong Buy Rating and Growth Outlook
Kratos drones & defense tech are booming, with strong growth, rising demand, and shares seen climbing from $70 toward $119.
NOTRELOAD AI
Playtika Launches Strategic Review to Boost Shareholder Value
Playtika is reviewing ways to grow its value, with expert advice, but no decision yet on selling, merging, or making changes.
Deutsche Bank Downgrades Avis Budget to Hold – Not a Sell Signal
Deutsche Bank cut Avis to Hold: stock looks overpriced now, though short-term gains possible; long-term outlook still positive.
ImmunityBio Quickly Fixes FDA Ad Concerns: Podcast Pulled, TV Spot Never Aired
ImmunityBio addressed FDA ad concerns, removed a podcast, and clarified ANKTIVA info while tightening rules on future promotions.
Tyra Biosciences Receives Buy Rating – Key 2026 Data Ahead
Tyra Biosciences’ dabogratinib shows promise: works well for bladder cancer & dwarfism with fewer side effects. Big 2026 trials ahead.
Jefferies Upgrades Twilio to Buy, Raises Price Target to $160
Jefferies upgraded Twilio to Buy, seeing big potential in its Voice AI, which could boost growth and profits over the coming years.